Tuesday, October 28, 2025 6:22:30 AM
Wall Street doesn’t wait for “massive revenues” to arrive first
It sure does...why did it take Wall-Street over 2 years to identify Nvidia as the major player in the AI and Data Center businesses? Even when Jensen Huang was touting EGX, Blackwell and Titan chips that were being installed in some of the most prestigious hospitals in America to help cancer research, being installed in every Tesla with FSD/Auto Pilot, and massive amounts EGX Chips were being up in every major data center the SP still lagged at $19. It took over 2 years for Wall Street to "wake-up" and realize wtf was happening. It wasn't until Nvidia was beating earnings estimates by 75-100% in some cases that the stick took off. Why? Because Nvidia wasn't backed by Wall Street via a IPO (it was a established Company with a niche market in gaming chips aka: GPUs), and recent failures in the mobile market made Wall Street skeptical. But the earnings where so far off the charts that WS played catch up very quicky. Hence the huge returns from 2019-2024. Amazon and Tesla both took a similar path as Nvidia if you look at where they came from, and where they are now. It took showing revenue and PROFITS to drive those stocks higher, numbers put together by the likes of BDO and announced in Quarterly calls. Numbers that could not be argued. Numbers that make things no longer speculative, but concrete. This is what NWBO must do for a rising SP. No more, no less. Of course MHRA approval will change things, but IMO the SP wont rise much until NW Management can show WS they can capitalize on the approval and make money off it. I dont think it gets to $1 on approval. Its just my opinion. I sure hope I am wrong.
Take a look at these Quantum computing stocks that have had huge runs in the last 2/3 years but dont generate much profit yet, why? Because most of their IPOs were backed by Hedge Funds and large Wall Street players who served as underwriters....they had a vested interest right off the bat.
My point is Wall Street isn't always forward looking, contrary to what retail believes. Most times its earning and profit that drive SP higher, not speculation.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
